Advisory Services
One Partner.
Four Domains.
End-to-End Impact.
Specialist advisory across Pharma, MedTech/Biotech, Nutraceuticals, and Database & Registry — delivered through flexible, scalable engagement models built around your needs.
Domain One
Pharma Advisory
Science-to-Strategy. Evidence-to-Impact.
Comprehensive medical affairs advisory for pharmaceutical organisations — from pre-launch strategic positioning through post-market lifecycle management, clinical evidence generation, and pipeline intelligence.
Module A
Scientific Launch & Lifecycle Strategy
- Pre-launch medical strategy & KOL sensitisation
- Differentiated product positioning & label strategy
- Lifecycle management for mature & mega brands
- Medico-regulatory submissions — NDA, CTA, SEC
- Phase IV & observational study design
Module B
Clinical Evidence & Value Generation
- Real-world evidence & Phase IV programme design
- Publication strategy — manuscripts, consensus, position papers
- Registry design & investigator-initiated study support
- Medical governance & cross-functional alignment
- HEOR & value-communication frameworks
Module C
Pipeline Intelligence & Unmet Need Mapping
- NCE identification for first-time launch opportunities
- LCM strategy — FDC, innovative formulations, repurposing
- Competitive landscape & therapy evolution mapping
- Collaborate with R&D, regulatory & commercial for 5–10 yr pipeline
- SEC presentations & clinical waiver strategy
Domain Two
MedTech / Biotech Advisory
Specialist Advisory Beyond Pharma.
Clinical, regulatory, and strategic advisory for medical device and biologics organisations — from early-stage unmet need analysis through clinical investigation and post-market evidence generation.
Module A
Product Need Gap & Development Strategy
- Disease landscape & clinical unmet need analysis
- Competitive benchmarking for device/biologic positioning
- Clinical & regulatory pathway strategy
- HCP engagement for device evaluation & feedback
- Pre-launch evidence plan for market readiness
Module B
Clinical Investigation — Regulatory & Utility Validation
- IDE / IVD study design & conduct strategy
- Post-market clinical follow-up (PMCF) planning
- Real-world performance evidence generation
- Clinical utility validation & HCP adoption programmes
- Regulatory submission support & documentation
Domain Three
Nutraceuticals & Cosmeceuticals
Evidence for Health. Strategy for Adoption.
Scientific advisory for consumer health, functional nutrition, and cosmeceutical organisations — bridging ingredient science with clinical evidence, regulatory compliance, and HCP adoption strategy.
Module A
Product Need Gap & Development Strategy
- Market & disease gap analysis for functional health
- Ingredient science & clinical evidence review
- Product-claim alignment with target health outcomes
- HCP adoption strategy & prescriber engagement
- Consumer-to-clinical bridge communication
Module B
Claims Strategy for Target Population
- Scientific substantiation for health claims
- Structure-function claims development
- FSSAI / regulatory alignment
- HCP recommendation support documentation
- Evidence-based consumer communication strategy
Domain Four
Database & Registry Strategy
Real-World Intelligence for Clinical Decisions.
End-to-end real-world evidence and registry solutions — from database design and architecture through statistical analysis and publication, delivering insights that support label extension, payer conversations, and clinical decision-making.
Module A
Database Design & RWE Strategy
- Structure, source selection & data governance
- National / regional registry architecture
- Evidence generation from existing datasets
- Label extension & payer conversation support
- Longitudinal data strategy & management
Module B
Registry Architecture & Validation
- Disease registries for post-market safety monitoring
- Comparative effectiveness research design
- Patient-reported outcomes (PRO) integration
- Statistical analysis plans & clinically meaningful endpoints
- Manuscript development & publication strategy
How We Engage
Flexible. Scalable. Built Around Your Needs.
Three proven engagement structures — each designed to deliver maximum strategic value at every stage of your organisation's growth.
Typically 4–12 Weeks
Project-Based
Defined scope, clear timeline, and measurable deliverables. Ideal for organisations with a specific strategic need — a product launch, a study protocol, a publication plan, or a regulatory submission.
12 Months · Ongoing
1-Year Retainer
Ongoing strategic advisory with monthly engagement and on-demand support — designed for organisations building or growing their Medical Affairs capability and needing consistent expert access.
24 Months · Deep Integration
2-Year Strategic Partnership
Deep integration with your medical team — long-term evidence strategy, pipeline advisory, and full lifecycle management. The most impactful model for organisations committed to sustained Medical Affairs excellence.
Ready to Explore How Syvantae
Can Support Your Team?
Tell us about your challenge and we will outline the right approach.